Search - tctmd.com

Displaying 101 - 120 of 153

Sort: Relevancy | Date

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

March 18, 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

March 18, 2017

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

News Daily News

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

March 14, 2017

Scott Gottlieb, a Familiar Face at the FDA, Could Return as Commissioner

News Daily News

Scott Gottlieb, a Familiar Face at the FDA, Could Return as Commissioner

March 13, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

Definitive Trials Spur Sharp Uptick in Use of Endovascular Therapy for Acute Ischemic Stroke

News Conference News ISC 2017

Definitive Trials Spur Sharp Uptick in Use of Endovascular Therapy for Acute Ischemic Stroke

March 02, 2017

NOAC-Related Intracranial Hemorrhages May Not Be as Bad as Those Stemming From Warfarin

News Conference News ISC 2017

NOAC-Related Intracranial Hemorrhages May Not Be as Bad as Those Stemming From Warfarin

March 01, 2017

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

News Conference News CRT 2017

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Michael O'Riordan

February 27, 2017

Simple and Complex Bifurcation Cases

Presentation JIM 2017

Simple and Complex Bifurcation Cases

Presenter: Robert-Jan van Geuns

February 23, 2017

Boston Scientific Recalls All Lotus Valves, Including Lotus with Depth Guard

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

Distal LM Medina 1,1,1

Presentation JIM 2017

Distal LM Medina 1,1,1

Presenter: Robert-Jan van Geuns

February 10, 2017

News Daily News

Alirocumab to Remain On Market While Companies Clash Over Patents

Michael O'Riordan

February 09, 2017

Rivaroxaban’s “Overwhelming” Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

February 08, 2017

Managing Calcified Lesions

Presentation JIM 2017

Managing Calcified Lesions

Presenter: Robert-Jan van Geuns

February 08, 2017

ABSORB Lessons From Registries: Outcome Influenced by Experience and Technique

Presentation JIM 2017

ABSORB Lessons From Registries: Outcome Influenced by Experience and Technique

Presenter: Robert-Jan van Geuns

February 08, 2017

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

TCTMD’s Top 10 Most Popular Stories for January 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2017

February 01, 2017

Trump’s Immigration Order Quickly Hits Home for Some Foreign-Born Physicians

News Features

Trump’s Immigration Order Quickly Hits Home for Some Foreign-Born Physicians

January 31, 2017

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

News Daily News

How Low Can Cholesterol Go? Safety Not in Limbo for Patients With Very Low LDL on Alirocumab, Study Shows

Yael L. Maxwell

January 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.